Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure

被引:8
|
作者
Alladina, Jehan [1 ]
Levy, Sean D. [3 ]
Cho, Josalyn L. [4 ]
Brait, Kelsey L. [1 ]
Rao, Sowmya R. [5 ]
Camacho, Alexander [2 ]
Hibbert, Kathryn A. [1 ]
Harris, R. Scott [1 ,6 ]
Medoff, Benjamin D. [1 ]
Januzzi, James L. [2 ]
Thompson, B. Taylor [1 ]
Bajwa, Ednan K. [1 ]
机构
[1] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, 55 Fruit St,Bulfinch 148, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA
[3] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA
[4] Univ Iowa, Carver Coll Med, Div Pulm Crit Care & Occupat Med, Iowa City, IA USA
[5] Boston Univ, Sch Publ Hlth, Boston, MA USA
[6] Vertex Pharmaceut, Boston, MA USA
关键词
biomarkers; acute respiratory distress syndrome; mechanical ventilator weaning; LOWER TIDAL VOLUMES; MECHANICAL VENTILATION; DISTRESS-SYNDROME; CLINICAL-OUTCOMES; WEANING PATIENTS; ST2; INTERLEUKIN-6; PREDICTORS; STRATEGIES; MORTALITY;
D O I
10.1164/rccm.202005-1951OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Standard physiologic assessments of extubation readiness in patients with acute hypoxemic respiratory failure (AHRF) may not reflect lung injury resolution and could adversely affect clinical decision-making and patient outcomes. Objectives: We hypothesized that elevations in inflammatory plasma biomarkers sST2 (soluble suppression of tumorigenicity-2) and IL-6 indicate ongoing lung injury in AHRF and better inform patient outcomes compared with standard clinical assessments. Methods: We measured daily plasma biomarkers and physiologic variables in 200 patients with AIIRF for up to 9 days after intubation. We tested the associations of baseline values with the primary outcome of unassisted breathing at Day 29. We analyzed the ability of serial biomarker measurements to inform successful ventilator liberation. Measurements and Main Results: Baseline sST2 concentrations were higher in patients dead or mechanically ventilated versus breathing unassisted at Day 29 (491.7 ng/ml [interquartile range (IQR), 294.5-670.1 ng/ml] vs. 314.4 ng/ml [IQR, 127.5-550.1 ng/ml]; P = 0.0003). Higher sST2 concentrations over time were associated with a decreased probability of ventilator liberation (hazard ratio, 0.80 per log-unit increase; 95% confidence interval [CI], 0.75-0.83; P = 0.03). Patients with higher sST2 concentrations on the day of liberation were more likely to fail liberation compared with patients who remained successfully liberated (320.9 ng/ml [IQR, 181.1-495.6 ng/ml] vs. 161.6 ng/ml [IQR, 95.8-292.5 ng/ml]; P = 0.002). Elevated sST2 concentrations on the day of liberation decreased the odds of successful liberation when adjusted for standard physiologic parameters (odds ratio, 0.325; 95% CI, 0.119-0.885; P = 0.03). IL-6 concentrations did not associate with outcomes. Conclusions: Using sST2 concentrations to guide ventilator management may more accurately reflect underlying lung injury and outperform traditional measures of readiness for ventilator liberation.
引用
收藏
页码:1257 / 1265
页数:9
相关论文
共 50 条
  • [1] Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome
    Bajwa, Ednan K.
    Volk, Jessica A.
    Christiani, David C.
    Harris, R. Scott
    Matthay, Michael A.
    Thompson, B. Taylor
    Januzzi, James L.
    CRITICAL CARE MEDICINE, 2013, 41 (11) : 2521 - 2531
  • [2] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang, Dong-Hui
    Sun, Hao
    Shi, Jing-Pu
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 570 - 577
  • [3] Genetic Regulation Of Soluble Suppression Of Tumorigenicity-2 Expression In Acute Respiratory Distress Syndrome
    Chen, C. -Y.
    Barnett, I.
    Bajwa, E.
    Wei, Y.
    Wang, Z.
    Sul, L.
    Christiani, D. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [4] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang Dong-Hui
    Sun Hao
    Shi Jing-Pu
    中华医学杂志英文版, 2016, 129 (05) : 570 - 577
  • [5] Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
    Aimo, Alberto
    Vergaro, Giuseppe
    Ripoli, Andrea
    Bayes-Genis, Antoni
    Figal, Domingo A. Pascual
    de Boer, Rudolf A.
    Lassus, Johan
    Mebazaa, Alexandre
    Gayat, Etienne
    Breidthardt, Tobias
    Sabti, Zaid
    Mueller, Christian
    Brunner-La Rocca, Hans-Peter
    Tang, W. H. Wilson
    Grodin, Justin L.
    Zhang, Yuhui
    Bettencourt, Paulo
    Maisel, Alan S.
    Passino, Claudio
    Januzzi, James L.
    Emdin, Michele
    JACC-HEART FAILURE, 2017, 5 (04) : 287 - 296
  • [6] Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2018, 19 (03): : 228 - 228
  • [7] Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome
    Alladina, Jehan W.
    Levy, Sean D.
    Hibbert, Kathryn A.
    Januzzi, James L.
    Harris, R. Scott
    Matthay, Michael A.
    Thompson, B. Taylor
    Bajwa, Ednan K.
    CRITICAL CARE MEDICINE, 2016, 44 (09) : 1735 - 1743
  • [8] Plasma Levels of Soluble Suppression of Tumorigenicity-2 (sST2) Are Associated with Markers of Injury, Severity of Illness, and Outcomes in Mechanically Ventilated Patients with Acute Respiratory Failure
    Labar, A. S.
    Bain, W.
    Shah, F. A.
    Evankovich, J.
    Schaefer, C.
    Drohan, C. M.
    Kaufman, B. A.
    Redding, K. M.
    Finkelman, M.
    Qin, S.
    Wang, X.
    Zhang, Y.
    Nouraie, S.
    Lee, J.
    Morris, A.
    Mcverry, B. J.
    Kitsios, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure
    Gul, Ibrahim
    Yucel, Oguzhan
    Zararsiz, Abdullah
    Demirpence, Ozlem
    Yucel, Hasan
    Zorlu, Ali
    Yilmaz, Mehmet Birhan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (03): : 200 - 205
  • [10] Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis
    Zhang, Ying
    Fan, Zixu
    Liu, Hua
    Ma, Jianwei
    Zhang, Min
    CORONARY ARTERY DISEASE, 2020, 31 (07) : 628 - 635